{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Anaxirone",
  "nciThesaurus": {
    "casRegistry": "77658-97-0",
    "chebiId": "",
    "chemicalFormula": "C11H15N3O5",
    "definition": "A synthetic triepoxide alkylating agent with potential antineoplastic activity. Anaxirone alkylates DNA via actual or derived epoxide groups, resulting in inhibition of DNA synthesis. This agent has been shown to exhibit a broad spectrum of antineoplastic activity against experimental tumors, including those resistant to other alkylating agents.",
    "fdaUniiCode": "36R61Y789T",
    "identifier": "C950",
    "preferredName": "Anaxirone",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C475",
      "C574"
    ],
    "synonyms": [
      "1,2,4-triglycidylurazol",
      "ANAXIRONE",
      "Anaxirone",
      "TGU",
      "Triglycidylurazol"
    ]
  }
}